Analysts Barclays upgraded Keurig Dr Pepper (KDP) to overweight and raised target price to $36, expecting 15% upside ahead of coffee business spinoff
Barclays has upgraded Keurig Dr Pepper's stock rating to overweight, anticipating a rebound as the company progresses with its planned coffee business spinout, which is expected to enhance investor confidence.